Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Optimal anticoagulant treatment lies in a small therapeutic
window (an international normalised ratio (INR) close to 2.2-2.3)
irrespective of the indication for treatment. This is the conclusion of
Odén and Fahlén's large study of medical records from
anticoagulation clinics in Sweden (p 1073). They analysed records for
42 451 patients, with 3533 deaths and 1.25 million measurements of
INR. Their results confirmed the beneficial effects of anticoagulants
on thromboembolism when the INR had increased from 1.0 to 2.3 and the
substantially higher mortality with higher INR. The authors conclude
that more action should be taken to avoid episodes of high INR.